News
Performance
Hasn't fared well - amongst the low performers
Valuation
Seems to be overvalued vs the market average
Growth
Lagging behind the market in financials growth
Profitability
Average profitability - not good, not bad
Entry point
The stock is not in the overbought zone
Red flags
No red flag found
Go Pro! to unlock score, rank
and other metrics
How to use scorecard? Learn more
Vista Pharmaceuticals reports standalone net loss of Rs 0.12 crore in the June 2021 quarter
3 years ago•Business Standard
Vista Pharmaceuticals reports standalone net loss of Rs 0.48 crore in the December 2020 quarter